In a challenging year for biotechnology firms, PureTech Health PLC (PRTC) stock has touched a 52-week low, dipping to $16.81.

On Wednesday, Progyny Inc (PGNY) stock saw a decline, ending the day at $21.15 which represents a decrease of $-0.33 or -1.54% from the prior close of $21.48. The stock opened at $21.31 and touched a ...

Apart from the public sale, the business intends to make a private placement of $17 million worth of shares to Wellington Hadley Harbor Aggregator IV, an 11% Beta Bonics equity holder. The conclusion ...

Accolade Inc (ACCD) stock saw a modest uptick, ending the day at $6.89 which represents a slight increase of $0.01 or 0.15% from the prior close of $6.88. The stock opened at $6.87 and touched a low ...

Analysts at Leerink Partnrs lifted their FY2026 earnings estimates for Travere Therapeutics in a research report issued to ...

Investment analysts at Leerink Partnrs upped their FY2026 EPS estimates for shares of AstraZeneca in a note issued to ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has disclosed terms for an upsized $113M initial public offering.

During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a ...

CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...

Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States, underscoring a gradual ...

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Castle Biosciences (CSTL – Research Report) yesterday and set a price target ...